People were worried Lynch was retiring, he made it clear he was isolating due to Covid
Like many of us with disabilities, he was left behind. People craved his work but wouldn’t wear a mask so he could create safely
We need to start saving the canaries:
https://t.co/qerjxmdnXz
Today, Sana Biotechnology released significant clinical data: the first person with type 1 diabetes (T1D) who received deceased donor islets engineered to evade the immune system is producing insulin without immunosuppression.
Learn more here: https://t.co/CNJRQrnGMH
Josef and Anni Albers are famous designers who were married. But they only collaborated on one thing: holiday cards. See their best cards here. https://t.co/G68ULXphS9
Our film ‘What a cure feels like’ is an entrant in this year’s Smiley Charity Film Awards.
By voting for our film, you’ll help us to raise awareness of T1D and inspire hope for a future without T1D 💙
Click here to vote 👉 https://t.co/h1wkDcwK86
#BreakthroughT1D #WhatACureFeelsLike #cfa2025 #charityfilmawards #GBDoc
🔊Sound on!🔊
We're excited to introduce our new film, ‘What a cure feels like’, celebrating our transformation to Breakthrough T1D!
The film features real people affected by type 1 diabetes (T1D) and captures the relentless nature of living with T1D and the hundreds of extra decisions made each day.
We would like to say a special thank you to @tara_humphrey and her daughter Tahlia, @LisWarren, @joem_ and his partner Salman and @Jonpeach5 who shared their experiences and worked alongside us to create this film.
Together, let's raise awareness and inspire hope for a future without T1D💙
#BreakthroughT1D #WhatACureFeelsLike #T1D #GBDoc
The story of Canada Dry begins with John J. McLaughlin, a pharmacist from Enniskillen, Ontario. He was the son of Robert McLaughlin, founder of the McLaughlin Carriage and McLaughlin Motor Car.
In 1890, John was working at a soda factory in Brooklyn, New York.
🧵2/9
Accidents happen... but you can STILL support me in the Breakthrough T1D Ride. Help create a world without type 1 diabetes (T1D). https://t.co/SXnxgYD3kq
Breaking News: The FDA has denied approval for Novo Nordisk’s once-weekly #insulin icodec in the U.S. Approval is unlikely in 2024. Learn more about the details and next steps here - https://t.co/gv4ngoPMjX. #Diabetes#Insulin#FDA#HealthNews